Skip Navigation

Age and Ageing 2005 34(6):626-632; doi:10.1093/ageing/afi202
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary data
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sorensen, L.
Right arrow Articles by Roberts, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sorensen, L.
Right arrow Articles by Roberts, M. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Medication management at home: medication-related risk factors associated with poor health outcomes

Lene Sorensen1, Julie A. Stokes1, David M. Purdie2, Michael Woodward3 and Michael S. Roberts1

1 Therapeutics Research Unit, Department of Medicine, University of Queensland, Queensland, Australia
2 Northern California Cancer Center, California, USA
3 Aged and Residential Care Services, Austin Health, Melbourne, Australia

Address correspondence to: L. Sorensen at Pharmakon, Milnersvej 42, 3400 Hillerod, Denmark. Email: LES{at}pharmakon.dk

Background: some patients may have medication-related risk factors only identified by home visits, but the extent to which those risk factors are associated with poor health outcomes remains unclear.

Objective: to determine the association between medication-related risk factors and poor patient health outcomes from observations in the patients’ homes.

Design: cross-sectional study.

Setting: patients’ homes.

Subjects: 204 general practice patients living in their own homes and at risk of medication-related poor health outcomes.

Methods: medications and medication-related risk factors were identified in the patients’ homes by community pharmacists and general practitioners (GPs). The medication-related risk factors were examined as determinants of patients’ self-reported health related quality of life (SF-36) and their medication use, as well as physicians’ impression of patient adverse drug events and health status.

Results: key medication-related risk factors associated with poor health outcomes included: Lack of any medication administration routine, therapeutic duplication, hoarding, confusion between generic and trade names, multiple prescribers, discontinued medication repeats retained and multiple storage locations. Older age and female gender were associated with some poorer health outcomes. In addition, expired medication and poor adherence were also associated with poor health outcomes, however, not independently.

Conclusion: the findings support the theory that polypharmacy and medication-related risk factors as a result of polypharmacy are correlated to poor health outcomes.

Keywords: medication, risk factors, in-home, elderly

Received July 13, 2004; accepted in revised form August 24, 2005.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
J. George, K. Munro, D. J McCaig, and D. C Stewart
Prescription Medications: Beliefs, Experiences, Behavior, and Adherence of Sheltered Housing Residents
Ann. Pharmacother., December 1, 2006; 40(12): 2123 - 2129.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
D.A. Gorard
Escalating polypharmacy
QJM, November 1, 2006; 99(11): 797 - 800.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.